Use of hydroxyethyl starch in sepsis research: A systematic review with meta-analysis

被引:3
|
作者
Johansen, Jes R. [1 ]
Perner, Anders [1 ]
Brodtkorb, Julie H. [1 ]
Moller, Morten H. [1 ]
机构
[1] Univ Copenhagen, Rigshosp, Dept Intens Care, Copenhagen, Denmark
关键词
adverse effects; hydroxyethyl starch (HES) 130/0.38-0.45; sepsis; RESUSCITATION; 6-PERCENT; MANAGEMENT; OUTCOMES; SALINE;
D O I
10.1111/aas.13954
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: After being used for more than a decade the use of hydroxyethyl starch (HES) 130/0.38-0.45 in clinical practice was discouraged because of serious adverse events including bleeding, acute kidney injury and death. But could these adverse effects have been discovered sooner? By comparing the summary effect estimates of the adverse effects of HES 130/0.38-0.45 in different study designs we aimed to disclose any signal of this. Methods: We systematically searched MEDLINE, EMBASE and Cochrane Library and hand-searched the reference lists of relevant studies to identify studies for inclusion. Eligible trials were randomised clinical trials (RCTs) and observational studies in patients with sepsis and randomised trials in animals with induced sepsis comparing HES 130/0.38-0.45 to any type of crystalloid. Relevant outcomes were all-cause mortality at longest follow-up, renal replacement therapy (RRT), acute kidney injury (AKI) and bleeding. We extracted data, conducted conventional meta-analyses and assessed the risk of bias and the quality of evidence. Results: We included 8 RCTs including 3,273 patients, 1 observational study including 379 patients and 5 randomised animal trials including 94 test animals. There was no suggestion of interaction in subgroup analyses comparing the different study designs for any outcomes (all-cause mortality at longest follow-up p = .33; RRT p = .70; AKI p = .63; bleeding p = .20). Conclusions: We observed no interaction between the summary effect estimates of RCTs, observational studies in patients and randomised animal trials for any of the outcomes. Accordingly, we found no evidence indicating that the adverse effects of HES 130/0.38-0.45 could have been discovered sooner. Systematic review registration: PROSPERO ID: CRD42018103422. Protocol Johansen JR, Perner A, Brodtkorb JH, Moller MH. Use of hydroxyethyl starch in sepsis research: Protocol for a systematic review. Acta Anaesthesiol Scand. 2019;63:814-818.
引用
收藏
页码:1355 / 1364
页数:10
相关论文
共 50 条
  • [21] Diagnostic Value of Presepsin for Sepsis A Systematic Review and Meta-Analysis
    Zhang, Jing
    Hu, Zhi-De
    Song, Jia
    Shao, Jiang
    MEDICINE, 2015, 94 (47) : e2158
  • [22] MACROLIDES AS ADJUNCTIVE TREATMENT IN SEPSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Gil Villanueva, Cary Amiel
    Luzano, Jonathan
    Lennin Roque, Vladimir
    Bella Siasoco, Ma.
    RESPIROLOGY, 2019, 24 : 216 - 216
  • [23] Prebiotics and sepsis in infants: An updated systematic review and meta-analysis
    Qin, Yuejia
    Pan, Linhui
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 33 (09): : 999 - 1005
  • [24] Silent existence of eosinopenia in sepsis: a systematic review and meta-analysis
    Yao Lin
    Jiabing Rong
    Zhaocai Zhang
    BMC Infectious Diseases, 21
  • [25] Accuracy of Presepsin in Sepsis Diagnosis: A Systematic Review and Meta-Analysis
    Wu, Jiayuan
    Hu, Liren
    Zhang, Gaohua
    Wu, Fenping
    He, Taiping
    PLOS ONE, 2015, 10 (07):
  • [26] EFFECT OF DEXMEDETOMIDINE ON MORTALITY IN SEPSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Hasegawa, Daisuke
    Sato, Ryota
    Prasitlumkum, Narut
    Nishida, Kazuki
    Nishida, Osamu
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 735 - 735
  • [27] Macrolides as Adjunctive Treatment in Sepsis: A Systematic Review and Meta-Analysis
    Villanueva, C. G.
    Luzano, J. R.
    Roque, V. A.
    Siasoco, M. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [28] Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis
    Volbeda, M.
    Wetterslev, J.
    Gluud, C.
    Zijlstra, J. G.
    van der Horst, I. C. C.
    Keus, F.
    INTENSIVE CARE MEDICINE, 2015, 41 (07) : 1220 - 1234
  • [29] Silent existence of eosinopenia in sepsis: a systematic review and meta-analysis
    Lin, Yao
    Rong, Jiabing
    Zhang, Zhaocai
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [30] Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
    Wacker, Christina
    Prkno, Anna
    Brunkhorst, Frank M.
    Schlattmann, Peter
    LANCET INFECTIOUS DISEASES, 2013, 13 (05): : 426 - 435